Niva Bupa Health Insurance Company Limited has informed the Exchange regarding Appointment of Mr. Christopher Patrick Carroll as Non- Executive Director of the company w.e.f. May 15, 2026.
NIVABUPA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Niva Bupa's Board meeting on May 8, 2026 approved multiple changes. Two Non-Executive Directors — Ms. Penelope Ruth Dudley and Mr. Carlos Antonio Jaureguizar Ruiz-Jarabo — resigned effective immediately, citing insufficient time due to other professional commitments. Simultaneously, Mr. Christopher Patrick Carroll (CEO of Bupa Global, India & UK) and Ms. Siobhan Djihan Moynihan (CFO of Bupa Global, India & UK) were appointed as Additional Non-Executive Directors effective May 15, 2026, subject to shareholder approval within 3 months. Internally, Mr. Ankur Kharbanda was elevated from Executive Director & Chief Business Officer to Executive Director & Deputy CEO. Additionally, the Board approved a large ESOP grant of 12,251,268 options at ₹72.45 per option to eligible employees under ESOP Scheme 2024.
The simultaneous resignation and replacement of two Non-Executive Directors with Bupa Global executives suggests a planned leadership transition aligned with the parent company. The ESOP grant of over 12 million options signals retention focus. Shareholders should note the upcoming shareholder approval requirement for the new director appointments.